Glutathione‐Responsive Nanoparticles of Camptothecin Prodrug for Cancer Therapy-Reference-Cited by-同舟云学术

Glutathione‐Responsive Nanoparticles of Camptothecin Prodrug for Cancer Therapy

Published:2022-11-28 Issue:3 Volume:10 Page:2205246
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Advanced Science

Author:

Zhang Lingpu¹,Zhu Lin¹,Tang Lin¹,Xie Jiayi²,Gao Yajuan³,Yu Changyuan¹,Shang Kun³,Han Hongbin³,Liu Chaoyong¹^ORCID,Lu Yunfeng¹

Affiliation:

1. Beijing Advanced Innovation Center for Soft Matter Science and Engineering College of Life Science and Technology Beijing University of Chemical Technology Beijing 100029 P. R. China

2. Department of Automatic Tsinghua University Peking University Third Hospital Beijing Key Laboratory of Magnetic Resonance Imaging Devices and Technology Beijing 100191 P. R. China

3. Department of Radiology Peking University Third Hospital Institute of Medical Technology Peking University Health Science Center Beijing 100019 P. R. China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202205246

Reference29 articles.

1. Camptothecin

2. On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex

3. The long story of camptothecin: From traditional medicine to drugs

4. Camptothecin: current perspectives

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel supramolecule combining the pharmacological benefits of berberin and catechin for the prevention and treatment of cervical cancer;Colloids and Surfaces A: Physicochemical and Engineering Aspects;2024-10

2. An Integrative Probe for Tumor Therapy and Dual-Modal Self-Evaluation Imaging of Therapeutic Efficacy;ACS Materials Letters;2024-09-05

3. Tumor microenvironment-responsive drug self-delivery systems to treat cancer and overcome MDR;Rare Metals;2024-08-10

4. A fibroblast activation protein α-activatable nanoagent co-delivering diethyldithiocarbamate and copper for tumor therapy and imaging;Acta Biomaterialia;2024-08

5. Prediction of immunotherapy response of bladder cancer with a pyroptosis-related signature indicating tumor immune microenvironment;Frontiers in Pharmacology;2024-06-25